Bio-Techne announced Wilson Wolf Manufacturing has met the trailing 12-month EBITDA target of $55M, triggering Bio-Techne’s initial investment in the company, which is expected to close at the end of March 2023. Bio-Techne’s $257M investment will give the company a 20% ownership stake in Wilson Wolf. The agreement includes the right to acquire the remaining ownership in Wilson Wolf for $1B upon its achievement of $226M in trailing 12-month revenue or $136M in EBITDA. If the remaining milestone is not met by December 31, 2027, Bio-Techne has the right to acquire Wilson Wolf for ~4.4x trailing 12-month revenue.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TECH:
